Literature DB >> 31595787

Temporizing External Fixation vs Splinting Following Ankle Fracture Dislocation.

Richard A Wawrose1, Leonid S Grossman1, Matthew Tagliaferro1, Peter A Siska1, Gele B Moloney1, Ivan S Tarkin1.   

Abstract

BACKGROUND: Closed reduction and splinting followed by outpatient management is standard of care for temporizing most ankle fractures. However, ankle fracture-dislocation potentially warrants a different approach based on the propensity for loss of reduction. The purpose of this study was to determine the rate of complications associated with closed reduction and splinting of unstable ankle fracture-dislocations. Further, we sought to determine the efficacy of immediate external fixation as an alternative to splinting in cases too swollen for acute operation.
METHODS: This retrospective chart review analyzed all ankle-fracture dislocations that came through a large health care system from 2008 to 2018. Patients managed with acute open reduction internal fixation (ORIF) and open fractures were excluded. In patients managed late, the cohorts were divided into those temporized with closed reduction/splinting vs external fixation. Reduction quality and splint technique were additionally assessed in splinted patients. A total of 354 closed ankle fracture-dislocations were identified: 298 patients (84%) underwent ORIF within 48 hours and were excluded; 28 (15 female/13 male, average age 46.8 years) were placed in an external fixator and 28 (22 female/6 male, average age 57.2 years) were reduced, splinted, and discharged.
RESULTS: At follow-up, 14 of the patients (50%) in the splint group developed loss of reduction and 5 of these patients (17.6%) developed anteromedial skin necrosis from skin tenting. None of the patients in the ex-fix group developed loss of reduction or skin necrosis. The rate of redislocation and the rate of development of skin necrosis was statistically higher in cases temporized with a splint versus an external fixator (P < .01 and P = .05, respectively).
CONCLUSION: We found that in ankle fracture-dislocations not treated with acute ORIF, splint immobilization was associated with an increased risk of complications, including redislocation and skin necrosis, when compared to a temporizing external fixator. LEVEL OF EVIDENCE: Level III, retrospective comparative study.

Entities:  

Keywords:  ankle fracture dislocation; complications; external fixation; splint

Mesh:

Year:  2019        PMID: 31595787     DOI: 10.1177/1071100719879431

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  5 in total

1.  Clinical and Radiological Results after Fracture-Dislocations of the Ankle: A Medium- to Long-Term Followup Study.

Authors:  Vincenzo De Luna; Alessandro Caterini; Chiara Casci; Martina Marsiolo; Kristian Efremov; Fernando De Maio; Pasquale Farsetti
Journal:  J Funct Morphol Kinesiol       Date:  2022-03-25

2.  Association of Delayed Surgery for Ankle Fractures and Patient-Reported Outcomes.

Authors:  Kristian Pilskog; Teresa Brnic Gote; Heid Elin Johannessen Odland; Knut Andreas Fjeldsgaard; Håvard Dale; Eivind Inderhaug; Jonas Meling Fevang
Journal:  Foot Ankle Int       Date:  2022-02-20       Impact factor: 3.569

Review 3.  A systematic review of ankle fracture-dislocations: Recent update and future prospects.

Authors:  Mu-Min Cao; Yuan-Wei Zhang; Sheng-Ye Hu; Yun-Feng Rui
Journal:  Front Surg       Date:  2022-08-09

4.  Establishing a low-risk zone for a temporary extra-articular calcaneo-tibial pin fixation in an unstable ankle or subtalar joint.

Authors:  Ik Yang; Ho Won Lee; Huiying Xu; Seung Rim Kang; Hyong Nyun Kim
Journal:  Sci Rep       Date:  2022-08-03       Impact factor: 4.996

5.  Temporizing cast immobilization is a safe alternative to external fixation in ankle fracture-dislocation while posterior malleolar fragment size predicts loss of reduction: a case control study.

Authors:  Rene Gerlach; Andreas Toepfer; Matthijs Jacxsens; Viliam Zdravkovic; Primoz Potocnik
Journal:  BMC Musculoskelet Disord       Date:  2022-07-22       Impact factor: 2.562

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.